Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ELVN

Enliven Therapeutics Inc

May 29 • 04:00PM ET

39.57

-1.08 -2.66 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ERAS IDYA TNGX CGON KYMR NUVL BMRN INCY RYTM AXSM

| Held by: VTI IWM VXF IWO IBB SCHA XPH VTWO DFAS IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.66	Insider Own	22.91%	Shs Outstand	60.89M	Perf Week	-6.34%
Market Cap	2.41B	Forward P/E	-	EPS next Y	-2.38	Insider Trans	-2.68%	Shs Float	46.95M	Perf Month	-6.67%
Enterprise Value	1.96B	PEG	-	EPS next Q	-0.40	Inst Own	83.52%	Short Float	10.91%	Perf Quarter	33.28%
Income	-98.78M	P/S	-	EPS this Y	4.34%	Inst Trans	1.56%	Short Ratio	4.74	Perf Half Y	82.35%
Sales	0.00M	P/B	5.31	EPS next Y	-36.02%	ROA	-25.74%	Short Interest	5.12M	Perf YTD	156.95%
Book/sh	7.45	P/C	5.33	EPS next 5Y	-18.38%	ROE	-26.64%	52W High	48.53 -18.46%	Perf Year	123.06%
Cash/sh	7.43	P/FCF	-	EPS past 3/5Y	46.65% 33.56%	ROIC	-21.79%	52W Low	14.78 167.64%	Perf 3Y	101.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.04% 5.58%	Perf 5Y	36.07%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.79%	Oper. Margin	-	ATR (14)	2.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	40.32	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.76	Recom	1.10
Dividend Gr. 3/5Y	- -	Current Ratio	40.32	EPS Q/Q	34.03%	SMA20	-4.26%	Beta	0.30	Target Price	56.78
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-3.59%	Rel Volume	0.69	Prev Close	40.65
Employees	60	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	47.06%	Avg Volume	1.08M	Price	39.57
IPO	Mar 12, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.34% -	Trades		Volume	747,626	Change	-2.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)